ClinicalTrials.gg
Drug

Daunorubicin clinical trials

Also written Cerubidine, Daunomycin and RP-13057.

Includes 9 studies of Daunorubicin citrate.

studies test it
104
open now
15
in phase 3
35
first study started
1990

How each study uses Daunorubicin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Daunorubicin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Dec 1979 · CERUBIDINE · NDA 050484 (FDA, Drugs@FDA)
European Union
23 Aug 2018 · Vyxeos liposomal (previously Vyxeos) · EMEA/H/C/004282 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

daunorubicin hydrochloride
48
Daunorubicin
38
daunomycin hydrochloride
8
Cerubidin
7
rubidomycin
5

Brand

Cerubidine
23

Development codes

RP-13057
7
NSC-82151
1

Other names

Daunomycin
17

Studies by the year they started

103 studies that test it; most in 1999 (7); 1 more planned to start later

Studies that test Daunorubicin, by start year
YearStudies
19901
19931
19941
19964
19971
19983
19997
20007
20014
20026
20033
20045
20053
20062
20074
20087
20091
20104
20111
20122
20134
20154
20165
20174
20181
20191
20202
20211
20222
20231
20247
20251
20263

Who runs them

Industry 7 · Other 97

National Cancer Institute (NCI) (17) · Children's Oncology Group (13) · St. Jude Children's Research Hospital (10) · Institute of Hematology & Blood Diseases Hospital, China (5) · SWOG Cancer Research Network (4) · Memorial Sloan Kettering Cancer Center (3) · Children's Cancer Group, China (2) · Alliance for Clinical Trials in Oncology (2)

Often tested with

Tested in the same studies.

Cytarabine (75) · Methotrexate (33) · Cyclophosphamide (33) · Etoposide (31) · Mercaptopurine (29) · Vincristine (28) · Dexamethasone (27) · Thioguanine (22)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 7 phase 3 studies under way

Daunorubicin is the comparator. A study of two new drugs counts under both.

  • 4Venetoclax · Institute of Hematology & Blood Diseases Hospital, China, The First Affiliated Hospital of Soochow University · next primary completion Feb 2029
  • 1CPX-351 · University of Ulm · next primary completion Jun 2027
  • 1Lisaftoclax · First Affiliated Hospital of Zhejiang University · next primary completion Dec 2029
  • 1Aclarubicin · First Affiliated Hospital of Zhejiang University · next primary completion Dec 2029
  • 1Gilteritinib · Institute of Hematology & Blood Diseases Hospital, China · next primary completion Feb 2029
  • 1Azacitidine · Institute of Hematology & Blood Diseases Hospital, China · next primary completion Feb 2029
  • 1Idarubicin · University Hospital, Angers
  • 1Cyclosporine · University Hospital, Angers
Reaching primary completion within a year · 6, 1 in phase 3

Studies that test Daunorubicin, phase 3 first.

Studies

Open first, then newest update. How each study uses Daunorubicin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 104

See all 104 studies that test Daunorubicin →

Given beside what is tested · 108 — Daunorubicin is usual care or a partner of the new treatment

Showing 20 of 108.

As the comparator · 27 — what is tested is compared with Daunorubicin

Showing 20 of 27.

Codes

What other systems call Daunorubicin · ClinicalTrials.gg INT007300

  • MeSH (NLM) D003630DaunorubicinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) ZS7284E0ZPDAUNORUBICINConfirmed FDA, NLM, Wikidata
  • RxNorm 3109Confirmed FDA, Wikidata
  • Wikidata Q411659daunorubicinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62091DaunorubicinOne source FDA
  • DrugBank DB00694One source Wikidata

Also registered as daunorubicin hydrochloride (UNII UD984I04LZ · RxNorm 81992).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.